Cyclin-Dependent Kinase 4/6 Inhibitors in Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer: Efficacy, Safety, and Clinical Integration. CDF [Internet]. 2024 Nov. 20 [cited 2026 May 13];53(03):6759-6. Available from: https://cuestionesdefisioterapia.com/index.php/es/article/view/3925